Clinical Trials on Actinic Keratosis

Total 1715 results

Novoxel Ltd.

Completed

Evaluation of The Efficacy and Safety of Tixel Treatment for the Treatment of Facial and/or Scalp Actinic Keratoses

Actinic Keratoses

Israel
Birken AG
University Hospital Tuebingen

Completed

The Efficacy and Tolerability of Oleogel-S-10 in Patients With Actinic Keratoses

Actinic Keratoses

Germany, Greece
Actavis Mid-Atlantic LLC

Completed

A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses

Actinic Keratoses

United States
Helsinki University Central Hospital

Active, not recruiting

New Treatments for Actinic Keratoses of the Scalp

Actinic Keratoses | Photodamaged Skin
Rhode Island Hospital

Completed

Nicotinamide for Prevention of Pre-malignant Actinic Keratosis in Kidney Transplant Recipients (NICE)

Actinic Keratoses
Maastricht University Medical Center

Active, not recruiting

The Influence of an E-learning Program on Recognition of Actinic Keratosis

Actinic Keratoses | Dermatology | E-learning

Netherlands
Spirig Pharma Ltd.

Terminated

Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients

Actinic Keratoses | Squamous Cell Carcinomas

Ireland, Austria, Netherlands, United Kingdom, Czech Republic, France, Germany, Switzerland, Turkey
Dong-A University

Completed

Efficacy in Ablative Fractional Laser Assisted Photodynamic Therapy According to Ablative Depth for Actinic Keratosis

Actinic Dermatosis

Korea, Republic of
Medical University of Graz

Completed

Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream

Actinic Keratoses

Austria
Shanghai Dermatology Hospital
Peking University First Hospital; Cancer Institute and Hospital, Chinese Academy... and other collaborators

Recruiting

Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention

Actinic Keratoses

China
Maastricht University Medical Center
Tergooi Hospital

Active, not recruiting

High- and Low-risk Actinic Keratosis Referrals to Secondary Care

Actinic Keratoses

Netherlands
Novoxel Ltd.

Completed

Efficacy and Safety of Tixel Treatment on Facial and/or Scalp Actinic Keratoses.

Actinic Keratoses

Israel
Icahn School of Medicine at Mount Sinai
LEO Pharma

Completed

Safety and Efficacy of Ingenol Mebutate 0.05% Gel When Used After Cryotherapy in the Hypertrophic Actinic Keratoses

Actinic Keratoses

United States
Dong-A University

Completed

Efficacy of Topical Calcipotriol-assisted AFL-PDT in Actinic Keratosis

Actinic Dermatosis

Korea, Republic of
University of California, San Francisco

Completed

Daylight Photodynamic Therapy for Actinic Keratosis

Actinic Keratoses

United States
Almirall, S.A.
Athenex, Inc.

Completed

A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp (AK003)

Actinic Keratoses

United States
Galderma R&D

Completed

PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK (SESAME 2)

Actinic Keratoses

Germany
Dermatology, Laser & Vein Specialists of the Carolinas

Completed

Bilateral Comparison of Treatment of Facial Actinic Keratoses Using Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Incubation Times

Actinic Keratoses

United States
Icahn School of Medicine at Mount Sinai
LEO Pharma

Completed

Treatment of Actinic Keratoses (AK) on the Face

Actinic Keratoses

United States
Rigel Dermatology

Completed

Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses

Actinic Keratoses

United States
Wright State University

Recruiting

Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia

Aging | Actinic Keratoses | Non-Melanoma Skin Cancer

United States
DUSA Pharmaceuticals, Inc.

Terminated

ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients

Skin Neoplasms | Actinic Keratoses

United States
Peplin

Completed

A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel

Actinic Keratoses

Australia, New Zealand
MEDA Pharma GmbH & Co. KG

Completed

A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQ

Actinic Keratoses
University Hospital Regensburg

Completed

Daylight-PDT With MAL for AK and Photodamaged Skin

Actinic Keratoses | Photodamaged Skin

Germany
Athenex, Inc.
TKL Research, Inc.

Completed

Single-Center Study Evaluating Systemic Exposure and Safety of KX2-391 Ointment 1% on the Face or Balding Scalp in Subjects With Actinic Keratosis

Actinic Keratoses

United States
Weill Medical College of Cornell University
YouV Labs Inc.

Completed

Validation of SHADE a Mobile Technology for Monitoring of Ultraviolet Exposure

Skin Cancer | Actinic Keratoses | Behavior, Health | Ultraviolet-Induced Change in Normal Skin | Behavior, Risk Reduction

United States
Clinuvel Pharmaceuticals Limited

Unknown

Phase II AK Study in Organ Transplant Patients

Carcinoma, Squamous Cell | Actinic Keratoses | Organ Transplant Recipients

Australia, Sweden, Switzerland, Italy, France, Belgium, Germany
Merete Haedersdal

Active, not recruiting

Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients With Actinic Keratosis (VAXAK)

Actinic Keratoses | Basal Cell Carcinoma | Squamous Cell Carcinoma

Denmark
University Hospital, Ghent
Erasmus Medical Center

Enrolling by invitation

HRQoL Keratinocyte Carcinomas

Actinic Keratoses | Basal Cell Carcinoma | Squamous Cell Carcinoma

Belgium, Netherlands
Galderma R&D

No longer available

Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease

Basal Cell Carcinoma | Bowen's Disease | Field Actinic Keratoses
Dolorgiet GmbH & Co. KG
d.s.h. statistical services GmbH; CenTrial GmbH

Completed

Study Whose Purpose is to Find an Optimal Dose for the Treatment With AK 3012 in Patients With Actinic Keratosis

Actinic Keratosis Olsen Grade I/II

Germany
Sol-Gel Technologies, Ltd.

Completed

Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) Cream

Actinic Keratosis (AK)

United States
University of California, Davis

Completed

Dermatosis Papulosa Nigra (DPN)

Facial Dermatoses | Seborrheic Keratoses

United States
Dr. Reddy's Laboratories Limited

Completed

A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period

Actinic Keratosis (AK)

United States
Assuta Hospital Systems

Completed

Evaluation of a Topical Treatment for Actinic Keratosis

Actinic Keratosis of Face and Scalp

Israel
Actavis Inc.

Completed

An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis

ACTINIC KERATOSIS

United States
LEO Pharma

Completed

Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%

Actinic Keratosis (AK)

Germany, United Kingdom, France
LEO Pharma

Completed

Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp

Actinic Keratosis (AK)

Germany
The Cleveland Clinic

Completed

Biomarker Database Registry for Photodynamic Therapy

Actinic Keratosis

United States
MEDA Pharma GmbH & Co. KG

Completed

A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients

Actinic Keratosis
Northwestern University

Withdrawn

Ingenol Mebutate Compared to Cryotherapy for the Treatment of Skin Lesions

Actinic Keratosis
Padagis LLC

Completed

To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis

Actinic Keratosis
Galderma R&D

Completed

Gene Expression in Renal Transplant Patients With Field Actinic Keratosis Undergoing Metvix® Photodynamic Therapy (PDT)

Actinic Keratosis

United Kingdom
Icahn School of Medicine at Mount Sinai
Bausch Health Americas, Inc.

Completed

Perimenstrual Acne With Clindamycin Phosphate and Benzoyl Peroxide

Actinic Keratosis

United States
Actavis Inc.

Completed

A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis

Actinic Keratosis

United States
Gage Development Company, LLC

Completed

Study Comparing GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic Keratoses

Actinic Keratosis

United States
Actavis Inc.

Completed

A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses

Actinic Keratosis

United States
LEO Pharma

Completed

The Real Life Topical Field Treatment of Actinic Keratosis Study (RAPID-ACT)

Actinic Keratosis

Netherlands
Actavis Inc.

Completed

Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis

Actinic Keratosis

United States

3

Subscribe